-
admin
Posts
Aesthetic procedures close to 35 million in 2023
Total surgical and non-surgical procedures increased by 3.4% in 2023, up to 34.9 million. MOUNT ROYAL, N.J., June 13, 2024 /PRNewswire/ — The International Society...
Well+Good and Philips Sonicare Team Up for Self-Care Switch Up to Encourage Healthier Smiles
NEW YORK, June 12, 2024 (GLOBE NEWSWIRE) — Well+Good, a leading health and wellness media brand, in partnership with Philips Sonicare, the #1 dental professional...
Huge Unveils the Next Wave of Intelligent Experiences
New client projects and executive hires announced New York, NY, June 12, 2024 (GLOBE NEWSWIRE) — Huge, the design and innovation company under Interpublic Group...
LGI Homes Introduces Eagle Landing, A Brand-New Community in Tacoma, Washington
TACOMA, Wash., June 12, 2024 (GLOBE NEWSWIRE) — LGI Homes, Inc. (NASDAQ: LGIH) announces the opening of its newest community less than 15 minutes from...
Bread Financial™ Signs Long-Term Agreement to Provide Dual Credit Card Program for Saks Fifth Avenue and Saks OFF 5TH
Program to include co-brand and private label credit cards with unique reward opportunities for cardmembers Existing Saks Fifth Avenue credit card portfolio to transition to...
Quoin Pharmaceuticals Announces Signing of Research Agreement with University College Cork (UCC), Ireland
Agreement will focus on the development of novel topical rapamycin (sirolimus) formulations as potential treatments for a number of rare and orphan diseases UCC’s proprietary...
Accolade to Announce Fiscal First Quarter 2025 Financial Results
SEATTLE, June 12, 2024 (GLOBE NEWSWIRE) — Accolade, Inc. (NASDAQ: ACCD) today announced that it will release fiscal first quarter 2025 financial results on Thursday, June...
Milestone Pharmaceuticals to Host KOL Event for Investors “Learnings from the Field: Expert Perspectives on PSVT in the Community Setting” on June 20, 2024
MONTREAL and CHARLOTTE, N.C., June 12, 2024 (GLOBE NEWSWIRE) — Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of...
Salarius Pharmaceuticals Announces 1-for-8 Reverse Stock Split
HOUSTON, June 12, 2024 (GLOBE NEWSWIRE) — Salarius Pharmaceuticals, Inc. (NASDAQ: SLRX), a clinical-stage biopharmaceutical company using protein inhibition and protein degradation to develop cancer...
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign
The integration with DocuSign, a pioneer in electronic signature technology, ensures that patients can securely and conveniently obtain their medical records NAPLES, Fla., June 12,...